Mays Cancer Center Annual Report Magazine

2019 issue

2019 Discovery of the Year presented to Dr. Zhijie “Jason” Liu

Zhijie “Jason” Liu, Ph.D., assistant professor of molecular medicine and CPRIT Scholar in Cancer Research, earned the 2019 Discovery of the Year Award from the Mays Cancer Center for his breast cancer research.
Sukeshi Patel Arora, M.D.

2019 Clinical Investigator of the Year award recognizes GI cancer expert

Medical Oncologist Sukeshi Patel Arora, M.D., was named the Mays Cancer Center's 2019 Clinical Investigator of the Year for her work with gastrointestinal cancer patients.
Patrick Sung, D.Phil.

Internationally known biochemist building world-class genome repair program

Renowned biochemist Patrick Sung, D.Phil., and his team are developing a nationally recognized genome repair program designed to create new therapeutics to treat difference types of cancer.

Researchers, physicians working together to develop new ways to fight liver cancer

Liver cancer tumors removed by surgeons are being studied by scientists with the goal of finding better ways to prevent, diagnose and treat hepatocellular carcinoma (HCC) in Hispanics in South Texas.
Ricardo Aguiar, M.D., Ph.D.

Clinical trial tests FDA-approved drug to treat diffuse large B-cell lymphoma

Ricardo Aguiar, M.D., Ph.D., professor of medicine and vice chief for research in the Division of Hematology and Medical Oncology, is conducting research with the goal of finding a cure for patients who are diagnosed with diffuse large B-cell lymphoma.
Enrique Diaz, M.D.

Research focused on improving lymphoma treatments for Hispanics

Enrique Diaz, M.D., director of the Lymphoma Program at the Mays Cancer Center, discovered that Hispanic Hodgkin’s lymphoma patients experience the same or better results from cancer treatment as Caucasian patients.
Daruka Mahadevan, M.D., Ph.D.

Cancer researcher relocates to lead early drug development at Mays Cancer Center

Cancer researcher Daruka Mahadevan, M.D., Ph.D., joins Mays Cancer Center and is leading early phase drug development. Dr. Mahadevan is concentrating on pancreatic cancer and lymphoma in his relocated lab.
Josephine Taverna, M.D.

Lung cancer tumors studied to discover new treatment, increase survival rate

Physician-scientist Josephine Taverna, M.D., is leading a multidisciplinary team performing advanced research with the goal of greatly increasing the survival rate for patients diagnosed with lung cancer.
Sukeshi Patel Arora, M.D. and patient Mary Churchill

Pancreas Tumor Center providing diagnosis, treatment plan in a day

The Pancreas Tumor Center, located at the Mays Cancer Center, is a patient-centered, multi-disciplined, one-day clinic that connects a variety of medical professionals with a patient in one location.
Jay K. Ferrell, M.D.

Head, neck cancer surgeons offer highly specialized care

Fellowship-trained surgeons remove head and neck tumors using Trans-Oral Robotic Surgery. The less invasive procedure maintains a patient's quality of life while it provides the ability to remove the primary tumor.
John Sarantopoulos, M.D.

Oncologist/investigator dedicates extensive career to drug development

While the Mays Cancer Center is dramatically increasing its early phase therapeutic development, John Sarantopoulos, M.D., has worked tirelessly researching next-generation cancer therapy since 2004.
Daniel Hughes, Ph.D.

Circle of Hope funds pilot project to improve survivors’ quality of life

A one-year pilot project is designed to prove the concept and initial effectiveness of a holistic, individualized yet structured approach to improve physical, mental and spiritual aspects of quality of life for survivors of all types of cancer.
1 2 3 4